B S Kramer

1.9k total citations
10 papers, 564 citations indexed

About

B S Kramer is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B S Kramer has authored 10 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B S Kramer's work include Colorectal Cancer Screening and Detection (3 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). B S Kramer is often cited by papers focused on Colorectal Cancer Screening and Detection (3 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). B S Kramer collaborates with scholars based in United States and Canada. B S Kramer's co-authors include Ruby Phelps, James L. Mulshine, S. M. Steinberg, R. Ilona Linnoila, Daniel C. Ihde, Margaret Edison, John C. Phares, May Lesar, Adi F. Gazdar and Philip C. Prorok and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

B S Kramer

10 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B S Kramer United States 8 335 166 164 130 67 10 564
Albert Schilling United States 13 276 0.8× 189 1.1× 40 0.2× 80 0.6× 47 0.7× 27 629
Rachael Sorg United States 14 219 0.7× 68 0.4× 89 0.5× 248 1.9× 47 0.7× 27 686
Masoud Babaei Iran 13 391 1.2× 122 0.7× 117 0.7× 216 1.7× 28 0.4× 21 781
Donald Poon Singapore 10 314 0.9× 90 0.5× 331 2.0× 103 0.8× 120 1.8× 14 774
Wittes Re United States 12 215 0.6× 87 0.5× 112 0.7× 71 0.5× 20 0.3× 24 377
Arzu Yaren Türkiye 14 283 0.8× 137 0.8× 89 0.5× 138 1.1× 23 0.3× 51 550
T M Mack United States 4 139 0.4× 80 0.5× 172 1.0× 101 0.8× 27 0.4× 6 697
John Vlachonikolis Greece 13 251 0.7× 61 0.4× 31 0.2× 140 1.1× 76 1.1× 20 535
Alessandro Iaculli Italy 10 252 0.8× 133 0.8× 90 0.5× 76 0.6× 118 1.8× 17 517
Carolina Ibáñez Chile 12 242 0.7× 108 0.7× 135 0.8× 59 0.5× 34 0.5× 47 507

Countries citing papers authored by B S Kramer

Since Specialization
Citations

This map shows the geographic impact of B S Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B S Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B S Kramer more than expected).

Fields of papers citing papers by B S Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B S Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B S Kramer. The network helps show where B S Kramer may publish in the future.

Co-authorship network of co-authors of B S Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of B S Kramer. A scholar is included among the top collaborators of B S Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B S Kramer. B S Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pinsky, Paul F., Anthony B. Miller, B S Kramer, et al.. (2007). Evidence of a Healthy Volunteer Effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Epidemiology. 165(8). 874–881. 164 indexed citations
2.
Dunn, Barbara K., B S Kramer, & Leslie G. Ford. (1998). PHASE III, LARGE-SCALE CHEMOPREVENTION TRIALS. Hematology/Oncology Clinics of North America. 12(5). 1019–1036. 15 indexed citations
3.
Prorok, Philip C., Arnold L. Potosky, John K. Gohagan, & B S Kramer. (1996). Prostate cancer screening: current issues. Cancer treatment and research. 86. 93–112. 7 indexed citations
4.
Ihde, Daniel C., James L. Mulshine, B S Kramer, et al.. (1994). Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.. Journal of Clinical Oncology. 12(10). 2022–2034. 194 indexed citations
5.
Ford, Leslie G., Otis W. Brawley, Jeffrey A. Perlman, et al.. (1994). The potential for hormonal prevention trials. Cancer. 74(S9). 2726–2733. 16 indexed citations
6.
Feuer, Eric J., Otis W. Brawley, Susan Nayfield, et al.. (1994). After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.. Journal of Clinical Oncology. 12(2). 368–377. 48 indexed citations
7.
Park, J.-G., et al.. (1990). Chemosensitivity Patterns and Expression of Human Multidrug Resistance-Associated MDR1 Gene by Human Gastric and Colorectal Carcinoma Cell Lines. JNCI Journal of the National Cancer Institute. 82(3). 193–198. 36 indexed citations
8.
Clamon, Gerald H., Ronald Feld, William K. Evans, et al.. (1985). Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial.. PubMed. 69(2). 167–77. 50 indexed citations
9.
Weiner, Roy S., B S Kramer, Gerald H. Clamon, et al.. (1985). Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer.. Journal of Clinical Oncology. 3(7). 949–957. 28 indexed citations
10.
Kramer, B S, et al.. (1984). Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.. PubMed. 68(10). 1295–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026